Moderna and Merck Announce Breakthrough in Cancer Vaccine Development
Moderna and Merck have announced a breakthrough in their collaborative cancer vaccine development, raising new hopes for cancer treatment. This advancement could usher in a new wave of cancer vaccines.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (38/100)Sources
Moderna and Merck's cancer vaccine raises new treatment hope
Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna's shares surging as much as 160%.
Read full article →Moderna, Merck breakthrough could usher in wave of cancer vaccines
The treatment involves pairing Merck's immunotherapy drug with a customized mRNA vaccine that instructs the immune system to attack specific cancer cells.
Read full article →Moderna, Merck breakthrough could usher in wave of cancer vaccines
Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy, which revs up the immune system, personalized cancer vaccines train the immune system to specifically target mutations found only on a person's tumor
By Reuters
Read full article →
